Eye Melanoma Market Report 2026

Eye Melanoma Market Overview

• Eye Melanoma market size has reached to $9.86 billion in 2025 • Expected to grow to $15.17 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Rising Prevalence Of Eye Cancer Boosts Growth Prospects For The Eye Melanoma Market • Market Trend: Adoption of Targeted Therapies in Eye Melanoma to Improve Treatment Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Eye Melanoma Market?

Eye melanoma is a type of cancer that develops in the melanocytes, the cells that produce melanin within the eye. It occurs in different parts of the eye, including the uvea, the iris, and the choroid. Eye melanoma is the most common primary intraocular cancer in adults and can cause vision problems, changes in eye color, and other symptoms depending on its location and size. The main types of eye melanoma occur in the uvea, sclera, and retina. The uvea refers to the middle layer of the eye that consists of the iris, ciliary body, and choroid, which contain blood vessels that supply nutrients to the eye and various forms of radiation therapy, including plaque brachytherapy, proton beam therapy, and stereotactic radiosurgery, are used to target and shrink uveal melanomas. They are diagnosed with imaging, biopsy, and eye exams and treated with treatments such as surgery, radiation therapy, targeted therapy, immunotherapy, and others provided by end users such as hospitals, clinics, and academic institutes.

What Is The Eye Melanoma Market Growth Forecast?

The eye melanoma market size is expected to see strong growth in the next few years. It will grow to $15.17 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to development of novel immunotherapies, increasing precision oncology adoption, growth in genetic testing, rising investment in rare cancer research, improved early screening programs. Major trends in the forecast period include growing focus on early cancer detection, rising adoption of targeted and immunotherapies, increased use of advanced ocular imaging, expansion of specialized oncology centers, growing clinical research in rare eye cancers.

Global Eye Melanoma Market Segmentation

1) By Site: Uvea, Sclera, Retina 2) By Diagnosis: Imaging, Biopsy, Eye Exam 3) By Treatment: Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy, Other Treatment 4) By End User: Hospitals And Clinics, Academic Institutes Subsegments: 1) By Uvea: Choroid Melanoma, Ciliary Body Melanoma, Iris Melanoma 2) By Sclera: Episcleral Melanoma, Scleral Surface Melanoma, Conjunctival Melanoma 3) By Retina: Macular Melanoma, Peripheral Retinal Melanoma, Optic Disc Melanoma

What Is The Driver Of The Eye Melanoma Market?

The increasing prevalence of eye cancer is expected to propel the growth of the eye melanoma market going forward. Eye cancer refers to the development of abnormal and uncontrolled cell growth within the eye's structures. The growing recognition and effective management of early cases are creating a heightened need for specialized therapies and interventions, propelled by improved detection methods, increased awareness, and advancements in treatment options. For instance, in 2025, according to the American Cancer Society, a US-based non-profit organization, there were approximately 3,140 new cases of eye and orbital cancers (mainly melanomas), including 1,620 in males and 1,520 in females. Further, there were about 490 deaths from these cancers, comprising 270 males and 220 females. Therefore, the increasing prevalence of eye cancer will drive the growth of the eye melanoma industry.

Key Players In The Global Eye Melanoma Market

Major companies operating in the eye melanoma market are Pfizer Inc., Johnson & Johnson, F. Hoffmann‑La Roche Ltd, Merck & Co. Inc, AbbVie Inc., Bayer AG, Novartis AG, Bristol‑Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., Amgen Inc., Castle Biosciences Inc., IDEAYA Biosciences Inc., Delcath Systems Inc., Immunocore Holdings plc, Aura Biosciences Inc., TriSalus Life Sciences Inc., Replimune Group Inc., Linnaeus Therapeutics, iOnctura, LES LABORATOIRES SERVIER, Immatics NV

Global Eye Melanoma Market Trends and Insights

Major companies are operating in the eye melanoma market focusing on developing technological advancements such as protein-kinase C (PKC) inhibitors to meet the rising demand for eye-preserving and effective systemic treatments. PKC inhibitors are small-molecule agents that selectively block PKC enzymes involved in tumor growth, offering a non-surgical alternative to traditional therapies such as plaque brachytherapy or enucleation. For instance, in March 2025, IDEAYA Biosciences, a US-based precision oncology company, launched darovasertib, a first-in-class PKC inhibitor for uveal melanoma. The therapy targets PKC isoforms implicated in tumor proliferation, showing tumor shrinkage rates of around 82% and eye-preservation rates of 61% in Phase 2 trials. Darovasertib can be used in both enucleation-eligible and plaque brachytherapy-eligible patients, providing a systemic, eye-sparing option for treating primary uveal melanoma.

What Are Latest Mergers And Acquisitions In The Eye Melanoma Market?

In January 2023, Health Network One, a prominent US-based specialty benefit management company, acquired a Premier Eye Care company for an undisclosed amount. With this acquisition, Health Network One aims to expand its provider network, enhance clinical quality, and drive innovation in ophthalmology services. Premier Eye Care, a US-based eye care services company, specializes in diagnosing and treating eye melanoma with various options like surgery, radiation, and laser therapy.

Regional Outlook

North America was the largest region in the eye melanoma market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Eye Melanoma Market?

The eye melanoma market consists of revenues earned by entities by providing fine needle aspiration (FNA) techniques, blood testing, and genetic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The eye melanoma market also includes sales of drugs and therapeutics such as chemotherapy, cryotherapy, and photodynamic therapy (PDT). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Eye Melanoma Market Report 2026?

The eye melanoma market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the eye melanoma industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.